Literature DB >> 19439162

Validation and comparison of two quantitative real-time PCR assays for direct detection of DMD/BMD carriers.

Mina Hayat Nosaeid1, Reza Mahdian, Somayeh Jamali, Fereshteh Maryami, Sadegh Babashah, Fahimeh Maryami, Morteza Karimipoor, Sirous Zeinali.   

Abstract

OBJECTIVES: To develop a robust and reliable assay for direct identification of female carriers of deletions in the dystrophin gene. DESIGN AND METHODS: We compared two quantitative real-time PCR approaches for the detection of the deletions of exons 4, 17, 47, and 50 in DMD/BMD carriers. One hundred and ten individuals from 26 unrelated families, including 8 large pedigrees characterized by having at least two DMD affected males, were studied. Carrier status of the subjects was also evaluated by MLPA.
RESULTS: The results showed the gene dosage ratio of 0.99+/-0.14 and 1.09+/-0.19 for normal individuals and 0.48+/-0.06 and 0.50+/-0.10 for carriers in SYBR green and TaqMan probe assays, respectively. Carrier status was accurately attributed in 100% of cases and confirmed by MLPA.
CONCLUSION: Quantitative real-time PCR can be used as a direct method for carrier detection in female relatives of DMD patients with known deletions. The results are comparable to the MLPA data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439162     DOI: 10.1016/j.clinbiochem.2009.04.016

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: The era of personalized medicine.

Authors:  Fawziah Mohammed; Alaa Elshafey; Haya Al-Balool; Hayat Alaboud; Mohammed Al Ben Ali; Adel Baqer; Laila Bastaki
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

2.  The effects of ovarian cancer cell-derived exosomes on vascular endothelial growth factor expression in endothelial cells.

Authors:  Mohammad Ghorbanian; Sadegh Babashah; Farangis Ataei
Journal:  EXCLI J       Date:  2019-10-09       Impact factor: 4.068

3.  Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.

Authors:  Amirreza Bitaraf; Sadegh Babashah; Masoud Garshasbi
Journal:  J Clin Lab Anal       Date:  2019-10-08       Impact factor: 2.352

4.  Novel manifestations of Warburg micro syndrome type 1 caused by a new splicing variant of RAB3GAP1: a case report.

Authors:  Raziyeh Khalesi; Ehsan Razmara; Golareh Asgaritarghi; Ali Reza Tavasoli; Yasser Riazalhosseini; Daniel Auld; Masoud Garshasbi
Journal:  BMC Neurol       Date:  2021-04-28       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.